BIOC Biocept Inc

Biocept Inc is an early commercial-stage molecular oncology diagnostics company. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA assays utilizing a standard blood sample.

As of 11/26/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  02/11/2013
Outstanding shares:  16,842,246
Average volume:  219,226
Market cap:   $62,653,155
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    09072V501
ISIN:        US09072V5012
Valuation   (See tab for details)
PE ratio:   18.57
PB ratio:   1.62
PS ratio:   0.95
Return on equity:   7.74%
Net income %:   4.71%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy